The present invention relates to an externally applied drug for the treatment of lumbar, cervical and bone joint diseases, which is characterized in that the present invention is prepared by the pharmaceutical raw materials with the following mix ratio by weight: 25 to 35 parts of Szechuan lovage rhizome, 20 to 30 parts of Chinese angelica, 35 to 45 parts of peach seed, 20 to 30 parts of safflower, 15 to 25 parts of sappan wood, 15 to 25 parts of cape jasmine fruit, 15 to 25 parts of nutgrass galingale rhizome, 15 to 25 parts of pangolin scales, 30 to 40 parts of leech, 1 to 3 parts of musk, 25 to 35 parts of dragon's blood, 20 to 30 parts of frankincense, 20 to 30 parts of myrrh, 15 to 25 parts of trogopterus dung, 15 to 25 parts of incised notopterygium rhizome, 15 to 25 parts of doubleteeth pubescent angilica root, 20 to 30 parts of pedate pinallia jackinthepulpit rhizome, 25 to 35 parts of scorpion, 15 to 25 parts of manchurian wildginger, 30 to 40 parts of dahurian angelica root, 25 to 35 parts of divaricate saposhnikovia root, 15 to 25 parts of great burdock achene, 20 to 30 parts of dried ginger, 25 to 35 parts of kusnezoff monkshood root, 25 to 35 parts of common monkshood mother root, 15 to 25 parts of pine nodular branch, 15 to 25 parts of siberian cocklour fruit, 20 to 30 parts of snake slough, 20 to 30 parts of tall gastrodia tuber, 30 to 40 parts of realgar, 35 to 45 parts of common floweringquince fruit, 15 to 25 parts of seaweed, 15 to 25 parts of kelp, 20 to 30 parts of lilac daphne flower bud, 20 to 30 parts of Peking euphorbia root, 25 to 35 parts of cochinchina momordica seed, 25 to 35 parts of Gleditsia sinensis stings, 25 to 35 parts of ephedra herb, 55 to 65 parts of hydrargyri oxydum rubrum, 10 to 20 parts of borax and 10 to 20 parts of borneol.